nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—CYP19A1—Betamethasone—ankylosing spondylitis	0.178	0.216	CbGbCtD
Mefloquine—BCHE—Triamcinolone—ankylosing spondylitis	0.173	0.21	CbGbCtD
Mefloquine—CYP19A1—Dexamethasone—ankylosing spondylitis	0.104	0.126	CbGbCtD
Mefloquine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0579	0.0704	CbGbCtD
Mefloquine—ABCB1—Betamethasone—ankylosing spondylitis	0.0376	0.0458	CbGbCtD
Mefloquine—ABCB1—Prednisolone—ankylosing spondylitis	0.0371	0.0452	CbGbCtD
Mefloquine—ABCB1—Prednisone—ankylosing spondylitis	0.0351	0.0427	CbGbCtD
Mefloquine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0347	0.0422	CbGbCtD
Mefloquine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0263	0.032	CbGbCtD
Mefloquine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0226	0.0274	CbGbCtD
Mefloquine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0223	0.0271	CbGbCtD
Mefloquine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0219	0.0266	CbGbCtD
Mefloquine—CYP3A4—Prednisone—ankylosing spondylitis	0.021	0.0256	CbGbCtD
Mefloquine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0206	0.0251	CbGbCtD
Mefloquine—ABCB1—Methotrexate—ankylosing spondylitis	0.0176	0.0214	CbGbCtD
Mefloquine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0131	0.016	CbGbCtD
Mefloquine—Eye disorder—Prednisone—ankylosing spondylitis	0.000333	0.00188	CcSEcCtD
Mefloquine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000333	0.00187	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000331	0.00186	CcSEcCtD
Mefloquine—Flushing—Prednisone—ankylosing spondylitis	0.000331	0.00186	CcSEcCtD
Mefloquine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000331	0.00186	CcSEcCtD
Mefloquine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000331	0.00186	CcSEcCtD
Mefloquine—Discomfort—Triamcinolone—ankylosing spondylitis	0.00033	0.00186	CcSEcCtD
Mefloquine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00033	0.00186	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000329	0.00185	CcSEcCtD
Mefloquine—Renal failure—Methotrexate—ankylosing spondylitis	0.000326	0.00184	CcSEcCtD
Mefloquine—Angiopathy—Prednisone—ankylosing spondylitis	0.000323	0.00182	CcSEcCtD
Mefloquine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000323	0.00181	CcSEcCtD
Mefloquine—Malaise—Betamethasone—ankylosing spondylitis	0.000321	0.00181	CcSEcCtD
Mefloquine—Malaise—Dexamethasone—ankylosing spondylitis	0.000321	0.00181	CcSEcCtD
Mefloquine—Oedema—Triamcinolone—ankylosing spondylitis	0.000321	0.0018	CcSEcCtD
Mefloquine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000321	0.0018	CcSEcCtD
Mefloquine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00032	0.0018	CcSEcCtD
Mefloquine—Vertigo—Betamethasone—ankylosing spondylitis	0.00032	0.0018	CcSEcCtD
Mefloquine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00032	0.0018	CcSEcCtD
Mefloquine—Syncope—Dexamethasone—ankylosing spondylitis	0.00032	0.0018	CcSEcCtD
Mefloquine—Syncope—Betamethasone—ankylosing spondylitis	0.00032	0.0018	CcSEcCtD
Mefloquine—Sweating—Methotrexate—ankylosing spondylitis	0.000318	0.00179	CcSEcCtD
Mefloquine—Shock—Triamcinolone—ankylosing spondylitis	0.000315	0.00177	CcSEcCtD
Mefloquine—Insomnia—Prednisolone—ankylosing spondylitis	0.000315	0.00177	CcSEcCtD
Mefloquine—Alopecia—Prednisone—ankylosing spondylitis	0.000315	0.00177	CcSEcCtD
Mefloquine—Shock—Methylprednisolone—ankylosing spondylitis	0.000315	0.00177	CcSEcCtD
Mefloquine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000314	0.00177	CcSEcCtD
Mefloquine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000314	0.00177	CcSEcCtD
Mefloquine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000313	0.00176	CcSEcCtD
Mefloquine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000313	0.00176	CcSEcCtD
Mefloquine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000313	0.00176	CcSEcCtD
Mefloquine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000313	0.00176	CcSEcCtD
Mefloquine—Mental disorder—Prednisone—ankylosing spondylitis	0.000312	0.00176	CcSEcCtD
Mefloquine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000312	0.00176	CcSEcCtD
Mefloquine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000311	0.00175	CcSEcCtD
Mefloquine—Erythema—Prednisone—ankylosing spondylitis	0.00031	0.00175	CcSEcCtD
Mefloquine—Malnutrition—Prednisone—ankylosing spondylitis	0.00031	0.00175	CcSEcCtD
Mefloquine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00031	0.00174	CcSEcCtD
Mefloquine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00031	0.00174	CcSEcCtD
Mefloquine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000309	0.00174	CcSEcCtD
Mefloquine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000309	0.00174	CcSEcCtD
Mefloquine—Convulsion—Betamethasone—ankylosing spondylitis	0.000309	0.00174	CcSEcCtD
Mefloquine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000308	0.00173	CcSEcCtD
Mefloquine—Hypertension—Betamethasone—ankylosing spondylitis	0.000308	0.00173	CcSEcCtD
Mefloquine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000303	0.00171	CcSEcCtD
Mefloquine—Myalgia—Betamethasone—ankylosing spondylitis	0.000303	0.00171	CcSEcCtD
Mefloquine—Anxiety—Betamethasone—ankylosing spondylitis	0.000302	0.0017	CcSEcCtD
Mefloquine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000302	0.0017	CcSEcCtD
Mefloquine—Discomfort—Dexamethasone—ankylosing spondylitis	0.0003	0.00169	CcSEcCtD
Mefloquine—Discomfort—Betamethasone—ankylosing spondylitis	0.0003	0.00169	CcSEcCtD
Mefloquine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000299	0.00168	CcSEcCtD
Mefloquine—Vision blurred—Prednisone—ankylosing spondylitis	0.000293	0.00165	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000292	0.00164	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000291	0.00164	CcSEcCtD
Mefloquine—Oedema—Betamethasone—ankylosing spondylitis	0.000291	0.00164	CcSEcCtD
Mefloquine—Oedema—Dexamethasone—ankylosing spondylitis	0.000291	0.00164	CcSEcCtD
Mefloquine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000291	0.00164	CcSEcCtD
Mefloquine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000291	0.00164	CcSEcCtD
Mefloquine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00029	0.00163	CcSEcCtD
Mefloquine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000289	0.00163	CcSEcCtD
Mefloquine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000288	0.00162	CcSEcCtD
Mefloquine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000288	0.00162	CcSEcCtD
Mefloquine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000287	0.00162	CcSEcCtD
Mefloquine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000287	0.00162	CcSEcCtD
Mefloquine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000287	0.00162	CcSEcCtD
Mefloquine—Shock—Betamethasone—ankylosing spondylitis	0.000286	0.00161	CcSEcCtD
Mefloquine—Shock—Dexamethasone—ankylosing spondylitis	0.000286	0.00161	CcSEcCtD
Mefloquine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000286	0.00161	CcSEcCtD
Mefloquine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000285	0.00161	CcSEcCtD
Mefloquine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000285	0.00161	CcSEcCtD
Mefloquine—Agitation—Prednisone—ankylosing spondylitis	0.000285	0.00161	CcSEcCtD
Mefloquine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000285	0.0016	CcSEcCtD
Mefloquine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000285	0.0016	CcSEcCtD
Mefloquine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000284	0.0016	CcSEcCtD
Mefloquine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000284	0.0016	CcSEcCtD
Mefloquine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000282	0.00159	CcSEcCtD
Mefloquine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000282	0.00159	CcSEcCtD
Mefloquine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000282	0.00158	CcSEcCtD
Mefloquine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000281	0.00158	CcSEcCtD
Mefloquine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000281	0.00158	CcSEcCtD
Mefloquine—Malaise—Prednisone—ankylosing spondylitis	0.00028	0.00158	CcSEcCtD
Mefloquine—Vertigo—Prednisone—ankylosing spondylitis	0.000279	0.00157	CcSEcCtD
Mefloquine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000278	0.00157	CcSEcCtD
Mefloquine—Syncope—Prednisone—ankylosing spondylitis	0.000278	0.00157	CcSEcCtD
Mefloquine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000278	0.00156	CcSEcCtD
Mefloquine—Urticaria—Prednisolone—ankylosing spondylitis	0.000277	0.00156	CcSEcCtD
Mefloquine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000277	0.00156	CcSEcCtD
Mefloquine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000276	0.00156	CcSEcCtD
Mefloquine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000276	0.00155	CcSEcCtD
Mefloquine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000273	0.00154	CcSEcCtD
Mefloquine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000272	0.00153	CcSEcCtD
Mefloquine—Hypotension—Betamethasone—ankylosing spondylitis	0.000272	0.00153	CcSEcCtD
Mefloquine—Angiopathy—Methotrexate—ankylosing spondylitis	0.00027	0.00152	CcSEcCtD
Mefloquine—Convulsion—Prednisone—ankylosing spondylitis	0.000269	0.00151	CcSEcCtD
Mefloquine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000269	0.00151	CcSEcCtD
Mefloquine—Hypertension—Prednisone—ankylosing spondylitis	0.000268	0.00151	CcSEcCtD
Mefloquine—Chills—Methotrexate—ankylosing spondylitis	0.000267	0.0015	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000265	0.00149	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000265	0.00149	CcSEcCtD
Mefloquine—Myalgia—Prednisone—ankylosing spondylitis	0.000264	0.00149	CcSEcCtD
Mefloquine—Arthralgia—Prednisone—ankylosing spondylitis	0.000264	0.00149	CcSEcCtD
Mefloquine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000264	0.00149	CcSEcCtD
Mefloquine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000264	0.00148	CcSEcCtD
Mefloquine—Anxiety—Prednisone—ankylosing spondylitis	0.000263	0.00148	CcSEcCtD
Mefloquine—Alopecia—Methotrexate—ankylosing spondylitis	0.000263	0.00148	CcSEcCtD
Mefloquine—Insomnia—Betamethasone—ankylosing spondylitis	0.000263	0.00148	CcSEcCtD
Mefloquine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000263	0.00148	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000262	0.00148	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000262	0.00147	CcSEcCtD
Mefloquine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000261	0.00147	CcSEcCtD
Mefloquine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000261	0.00147	CcSEcCtD
Mefloquine—Discomfort—Prednisone—ankylosing spondylitis	0.000261	0.00147	CcSEcCtD
Mefloquine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000261	0.00147	CcSEcCtD
Mefloquine—Erythema—Methotrexate—ankylosing spondylitis	0.000259	0.00146	CcSEcCtD
Mefloquine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000259	0.00146	CcSEcCtD
Mefloquine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000257	0.00145	CcSEcCtD
Mefloquine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000256	0.00144	CcSEcCtD
Mefloquine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000256	0.00144	CcSEcCtD
Mefloquine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000255	0.00143	CcSEcCtD
Mefloquine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000254	0.00143	CcSEcCtD
Mefloquine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000253	0.00143	CcSEcCtD
Mefloquine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000253	0.00143	CcSEcCtD
Mefloquine—Oedema—Prednisone—ankylosing spondylitis	0.000253	0.00143	CcSEcCtD
Mefloquine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000253	0.00142	CcSEcCtD
Mefloquine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000253	0.00142	CcSEcCtD
Mefloquine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000253	0.00142	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000251	0.00141	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000251	0.00141	CcSEcCtD
Mefloquine—Fatigue—Betamethasone—ankylosing spondylitis	0.000251	0.00141	CcSEcCtD
Mefloquine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000251	0.00141	CcSEcCtD
Mefloquine—Shock—Prednisone—ankylosing spondylitis	0.000249	0.0014	CcSEcCtD
Mefloquine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000248	0.0014	CcSEcCtD
Mefloquine—Tachycardia—Prednisone—ankylosing spondylitis	0.000247	0.00139	CcSEcCtD
Mefloquine—Skin disorder—Prednisone—ankylosing spondylitis	0.000246	0.00138	CcSEcCtD
Mefloquine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000245	0.00138	CcSEcCtD
Mefloquine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000244	0.00138	CcSEcCtD
Mefloquine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000241	0.00135	CcSEcCtD
Mefloquine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00024	0.00135	CcSEcCtD
Mefloquine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00024	0.00135	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000238	0.00134	CcSEcCtD
Mefloquine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000238	0.00134	CcSEcCtD
Mefloquine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000236	0.00133	CcSEcCtD
Mefloquine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000236	0.00133	CcSEcCtD
Mefloquine—Malaise—Methotrexate—ankylosing spondylitis	0.000234	0.00132	CcSEcCtD
Mefloquine—Vertigo—Methotrexate—ankylosing spondylitis	0.000233	0.00131	CcSEcCtD
Mefloquine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000232	0.00131	CcSEcCtD
Mefloquine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000231	0.0013	CcSEcCtD
Mefloquine—Urticaria—Betamethasone—ankylosing spondylitis	0.000231	0.0013	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000231	0.0013	CcSEcCtD
Mefloquine—Dizziness—Prednisolone—ankylosing spondylitis	0.000231	0.0013	CcSEcCtD
Mefloquine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00023	0.00129	CcSEcCtD
Mefloquine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00023	0.00129	CcSEcCtD
Mefloquine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00023	0.00129	CcSEcCtD
Mefloquine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00023	0.00129	CcSEcCtD
Mefloquine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00023	0.00129	CcSEcCtD
Mefloquine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000229	0.00129	CcSEcCtD
Mefloquine—Insomnia—Prednisone—ankylosing spondylitis	0.000229	0.00129	CcSEcCtD
Mefloquine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000227	0.00128	CcSEcCtD
Mefloquine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000227	0.00128	CcSEcCtD
Mefloquine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000226	0.00127	CcSEcCtD
Mefloquine—Convulsion—Methotrexate—ankylosing spondylitis	0.000225	0.00126	CcSEcCtD
Mefloquine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000223	0.00125	CcSEcCtD
Mefloquine—Myalgia—Methotrexate—ankylosing spondylitis	0.000221	0.00124	CcSEcCtD
Mefloquine—Chest pain—Methotrexate—ankylosing spondylitis	0.000221	0.00124	CcSEcCtD
Mefloquine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000221	0.00124	CcSEcCtD
Mefloquine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00022	0.00124	CcSEcCtD
Mefloquine—Rash—Prednisolone—ankylosing spondylitis	0.00022	0.00124	CcSEcCtD
Mefloquine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00022	0.00124	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000219	0.00123	CcSEcCtD
Mefloquine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000219	0.00123	CcSEcCtD
Mefloquine—Fatigue—Prednisone—ankylosing spondylitis	0.000218	0.00123	CcSEcCtD
Mefloquine—Headache—Prednisolone—ankylosing spondylitis	0.000218	0.00123	CcSEcCtD
Mefloquine—Discomfort—Methotrexate—ankylosing spondylitis	0.000218	0.00123	CcSEcCtD
Mefloquine—Confusional state—Methotrexate—ankylosing spondylitis	0.000213	0.0012	CcSEcCtD
Mefloquine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000212	0.00119	CcSEcCtD
Mefloquine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000212	0.00119	CcSEcCtD
Mefloquine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000212	0.00119	CcSEcCtD
Mefloquine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000209	0.00117	CcSEcCtD
Mefloquine—Asthenia—Betamethasone—ankylosing spondylitis	0.000209	0.00117	CcSEcCtD
Mefloquine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000209	0.00117	CcSEcCtD
Mefloquine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000208	0.00117	CcSEcCtD
Mefloquine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000207	0.00117	CcSEcCtD
Mefloquine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000207	0.00117	CcSEcCtD
Mefloquine—Nausea—Prednisolone—ankylosing spondylitis	0.000207	0.00117	CcSEcCtD
Mefloquine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000206	0.00116	CcSEcCtD
Mefloquine—Pruritus—Betamethasone—ankylosing spondylitis	0.000206	0.00116	CcSEcCtD
Mefloquine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000206	0.00116	CcSEcCtD
Mefloquine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000205	0.00115	CcSEcCtD
Mefloquine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000204	0.00115	CcSEcCtD
Mefloquine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000203	0.00114	CcSEcCtD
Mefloquine—Rash—Triamcinolone—ankylosing spondylitis	0.000202	0.00114	CcSEcCtD
Mefloquine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000202	0.00114	CcSEcCtD
Mefloquine—Rash—Methylprednisolone—ankylosing spondylitis	0.000202	0.00113	CcSEcCtD
Mefloquine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000201	0.00113	CcSEcCtD
Mefloquine—Urticaria—Prednisone—ankylosing spondylitis	0.000201	0.00113	CcSEcCtD
Mefloquine—Headache—Triamcinolone—ankylosing spondylitis	0.000201	0.00113	CcSEcCtD
Mefloquine—Headache—Methylprednisolone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Mefloquine—Body temperature increased—Prednisone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Mefloquine—Abdominal pain—Prednisone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Mefloquine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000199	0.00112	CcSEcCtD
Mefloquine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000199	0.00112	CcSEcCtD
Mefloquine—Hypotension—Methotrexate—ankylosing spondylitis	0.000198	0.00111	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000193	0.00109	CcSEcCtD
Mefloquine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000192	0.00108	CcSEcCtD
Mefloquine—Dizziness—Betamethasone—ankylosing spondylitis	0.000192	0.00108	CcSEcCtD
Mefloquine—Insomnia—Methotrexate—ankylosing spondylitis	0.000191	0.00108	CcSEcCtD
Mefloquine—Nausea—Triamcinolone—ankylosing spondylitis	0.00019	0.00107	CcSEcCtD
Mefloquine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00019	0.00107	CcSEcCtD
Mefloquine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00019	0.00107	CcSEcCtD
Mefloquine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000189	0.00106	CcSEcCtD
Mefloquine—Somnolence—Methotrexate—ankylosing spondylitis	0.000188	0.00106	CcSEcCtD
Mefloquine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000187	0.00105	CcSEcCtD
Mefloquine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000186	0.00105	CcSEcCtD
Mefloquine—Vomiting—Betamethasone—ankylosing spondylitis	0.000185	0.00104	CcSEcCtD
Mefloquine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000185	0.00104	CcSEcCtD
Mefloquine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000184	0.00104	CcSEcCtD
Mefloquine—Rash—Dexamethasone—ankylosing spondylitis	0.000183	0.00103	CcSEcCtD
Mefloquine—Rash—Betamethasone—ankylosing spondylitis	0.000183	0.00103	CcSEcCtD
Mefloquine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000183	0.00103	CcSEcCtD
Mefloquine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000183	0.00103	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000183	0.00103	CcSEcCtD
Mefloquine—Fatigue—Methotrexate—ankylosing spondylitis	0.000183	0.00103	CcSEcCtD
Mefloquine—Headache—Dexamethasone—ankylosing spondylitis	0.000182	0.00103	CcSEcCtD
Mefloquine—Headache—Betamethasone—ankylosing spondylitis	0.000182	0.00103	CcSEcCtD
Mefloquine—Asthenia—Prednisone—ankylosing spondylitis	0.000182	0.00102	CcSEcCtD
Mefloquine—Pruritus—Prednisone—ankylosing spondylitis	0.000179	0.00101	CcSEcCtD
Mefloquine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000174	0.000982	CcSEcCtD
Mefloquine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000173	0.000975	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000173	0.000974	CcSEcCtD
Mefloquine—Nausea—Betamethasone—ankylosing spondylitis	0.000173	0.000972	CcSEcCtD
Mefloquine—Nausea—Dexamethasone—ankylosing spondylitis	0.000173	0.000972	CcSEcCtD
Mefloquine—Urticaria—Methotrexate—ankylosing spondylitis	0.000168	0.000946	CcSEcCtD
Mefloquine—Dizziness—Prednisone—ankylosing spondylitis	0.000168	0.000943	CcSEcCtD
Mefloquine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000167	0.000942	CcSEcCtD
Mefloquine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000167	0.000942	CcSEcCtD
Mefloquine—Vomiting—Prednisone—ankylosing spondylitis	0.000161	0.000906	CcSEcCtD
Mefloquine—Rash—Prednisone—ankylosing spondylitis	0.00016	0.000899	CcSEcCtD
Mefloquine—Dermatitis—Prednisone—ankylosing spondylitis	0.00016	0.000898	CcSEcCtD
Mefloquine—Headache—Prednisone—ankylosing spondylitis	0.000159	0.000893	CcSEcCtD
Mefloquine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000156	0.000878	CcSEcCtD
Mefloquine—Asthenia—Methotrexate—ankylosing spondylitis	0.000152	0.000855	CcSEcCtD
Mefloquine—Nausea—Prednisone—ankylosing spondylitis	0.00015	0.000847	CcSEcCtD
Mefloquine—Pruritus—Methotrexate—ankylosing spondylitis	0.00015	0.000843	CcSEcCtD
Mefloquine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000145	0.000815	CcSEcCtD
Mefloquine—Dizziness—Methotrexate—ankylosing spondylitis	0.00014	0.000788	CcSEcCtD
Mefloquine—Vomiting—Methotrexate—ankylosing spondylitis	0.000135	0.000757	CcSEcCtD
Mefloquine—Rash—Methotrexate—ankylosing spondylitis	0.000133	0.000751	CcSEcCtD
Mefloquine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000133	0.00075	CcSEcCtD
Mefloquine—Headache—Methotrexate—ankylosing spondylitis	0.000133	0.000746	CcSEcCtD
Mefloquine—Nausea—Methotrexate—ankylosing spondylitis	0.000126	0.000708	CcSEcCtD
